DCF — UH SAMARITAN MEDICAL CENTER
Enterprise Value: $-59.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-59.8M
Enterprise Value
$-20.7M
PV of Cash Flows
$-39.0M
PV of Terminal Value
$-62.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $91.6M | $-2.7M | -3.0% | $-6.6M | $-6.0M |
| Year 2 | $94.4M | $-1.9M | -2.0% | $-5.9M | $-4.8M |
| Year 3 | $97.2M | $-0.9M | -1.0% | $-5.1M | $-3.8M |
| Year 4 | $100.1M | $-0.5M | -0.0% | $-4.7M | $-3.2M |
| Year 5 | $103.1M | $-0.2M | -0.0% | $-4.6M | $-2.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-59.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$88.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03477203122077898
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5